Table 1.

Patient demographics

Parameter	Value
Number of patients	34
Gender
Male	0 (0%)
Female	34 (100%)
Age (years)*	68.5 (53–87)
Bisphosphonate
Alendonate	29 (85.3%)
Zoledronic acid	3 (8.8%)
Pamidonate	2 (5.9%)
Duration of bisphosphonate use†
< 5 years	3 (15.8%)
> 5 years	16 (84.2%)

* Values are expressed as mean, with range in parentheses; ^†only 19 of 34 patients had documentation of duration of bisphosphonate use.